{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:10:44Z","timestamp":1751458244767},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11547-010-0591-3","type":"journal-article","created":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T08:19:56Z","timestamp":1286353196000},"page":"61-70","source":"Crossref","is-referenced-by-count":4,"title":["Ultrasonography in lesions of the carotid vessels in HIV positive patients"],"prefix":"10.1007","volume":"116","author":[{"given":"M.","family":"Cristofaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cicalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Busi Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Schinin\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Petrosillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bibbolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"key":"591_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"F.J.J. Palella","year":"1998","unstructured":"Palella FJJ, Delaney KM, Mormann AC et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853\u2013860","journal-title":"N Engl J Med"},{"key":"591_CR2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","volume":"351","author":"A. Carr","year":"1998","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodistrophy, hyperlipidaemia and insulin resistance. Lancet 351:1881\u20131883","journal-title":"Lancet"},{"key":"591_CR3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(05)60719-2","volume":"352","author":"E. Martinez","year":"1998","unstructured":"Martinez E, Gatell J (1998) Metabolic abnormalities and use of HIV-1 protease inhibitor Lancet 352:821\u2013822","journal-title":"Lancet"},{"key":"591_CR4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","volume":"351","author":"K. Henry","year":"1998","unstructured":"Henry K (1998) Severe premature coronary artery disease with protease inhibitors. Lancet 351:1328","journal-title":"Lancet"},{"key":"591_CR5","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(98)26026-0","volume":"351","author":"G. Behrens","year":"1998","unstructured":"Behrens G, Schmidt H, Meyer D et al (1998) Vascular complications associated with use of protease inhibitors. Lancet 351:1958","journal-title":"Lancet"},{"key":"591_CR6","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(05)78644-X","volume":"351","author":"D. Vittecoq","year":"1998","unstructured":"Vittecoq D, Escaut L, Monsuez JJ (1998) Vascular complications associated with use of protease inhibitors. Lancet 351:1959","journal-title":"Lancet"},{"key":"591_CR7","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(05)78645-1","volume":"351","author":"J. Laurence","year":"1998","unstructured":"Laurence J (1998) Vascular complications associated with use of protease inhibitors. Lancet 351:1960","journal-title":"Lancet"},{"key":"591_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00002030-200011100-00001","volume":"14","author":"P. Maggi","year":"2000","unstructured":"Maggi P, Serio G, Epifani G et al (2000) Premature lesions of the carotid vessels in HIV-infected patients treated with protease inhibitors. AIDS 14:123\u2013128","journal-title":"AIDS"},{"key":"591_CR9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00002030-200404300-00010","volume":"18","author":"P. Maggi","year":"2004","unstructured":"Maggi P, Lillo A, Perilli F et al (2004) A on behalf of the PREVALEAT Group Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study. AIDS 18:1023\u20131028","journal-title":"AIDS"},{"key":"591_CR10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/07853899509019256","volume":"27","author":"J. Constans","year":"1995","unstructured":"Constans J, Marchand JM, Conri C et al (1995) Asymptomatic atherosclerosis in HIV-posite patients: a case control study. Ann Med 27:683\u2013685","journal-title":"Ann Med"},{"key":"591_CR11","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","volume":"109","author":"P.Y. Hsue","year":"2004","unstructured":"Hsue PY, Lo JC, Franklin A et al (2004) Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109:1603\u20131608","journal-title":"Circulation"},{"key":"591_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","volume":"19","author":"J.S. Currier","year":"2005","unstructured":"Currier JS, Kendall MA, Zachin R et al (2005) Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 19:927\u2013933","journal-title":"AIDS"},{"key":"591_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejvs.2004.09.017","volume":"29","author":"G. Regina","year":"2005","unstructured":"Regina G, Impedovo G, Angiletta D et al (2005) Surgical experience with carotid stenosis in young HIV-1 positive patients under antiretroviral therapy: an emerging problem? Eur J Vadc Endovasc Surg 29:167\u2013170","journal-title":"Eur J Vadc Endovasc Surg"},{"key":"591_CR14","first-page":"204","volume":"8","author":"P. Maggi","year":"2006","unstructured":"Maggi P, Maserati R, Antonelli G (2006) Atherosclerosis in HIV patients: a new face for an old disease? AIDS Rev 8:204\u2013209","journal-title":"AIDS Rev"},{"key":"591_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2006.05.026","volume":"192","author":"P. Maggi","year":"2007","unstructured":"Maggi P, Perilli F, Lillo A et al (2007) Rapid progression of carotid lesions in HAART-treated HIV-1 patients. Atherosclerosis 192:407\u2013412","journal-title":"Atherosclerosis"},{"key":"591_CR16","unstructured":"Williams PL, Wu J, Cohn SE et al (2005) Risk of cardiovascular disease in HIV-infected adults with immune reconstitution. 12th Conference on Retroviruses and Opportunistic Infection; Boston, Massachusetts, USA, Abstract 867"},{"key":"591_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.mca.0000236292.86930.e3","volume":"18","author":"P. Maggi","year":"2007","unstructured":"Maggi P, Perilli F, Lillo A et al (2007) An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs atherosclerotic and arteritis patients: atherosclerotic or inflammatory lesions? Coron Artery Dis 18:23\u201329","journal-title":"Coron Artery Dis"},{"key":"591_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/oxfordjournals.aje.a010233","volume":"151","author":"L.E. Chambless","year":"2000","unstructured":"Chambless LE, Folsom AR, Clegg LX et al (2000) Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 151:478\u2013487","journal-title":"Am J Epidemiol"},{"key":"591_CR19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000107895","volume":"5","author":"J.M. Bray De","year":"1995","unstructured":"De Bray JM, Glatt B (1995) Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis 5:414\u2013426","journal-title":"Cerebrovasc Dis"},{"key":"591_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.2001.tb03900.x","volume":"946","author":"S.D. Fisher","year":"2001","unstructured":"Fisher SD, Lipshultz SE (2001) Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 946:13\u201322","journal-title":"Ann NY Acad Sci"},{"key":"591_CR21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","volume":"33","author":"J.S. Currier","year":"2003","unstructured":"Currier JS, Taylor A, Boyd F et al (2003) Coronary artery disease in HIVinfected individuals. J Acquir Immunodef Syndr 33:506\u2013512","journal-title":"J Acquir Immunodef Syndr"},{"key":"591_CR22","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","volume":"17","author":"M. Mary-Krause","year":"2003","unstructured":"Mary-Krause M, Cotte L, Simon A et al (2003) Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17:2479\u20132486","journal-title":"AIDS"},{"key":"591_CR23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","volume":"360","author":"S.D. Holmberg","year":"2002","unstructured":"Holmberg SD, Moorman AC, Williamson JM et al (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360:1747\u20131748","journal-title":"Lancet"},{"key":"591_CR24","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","volume":"349","author":"The DAD Study Group","year":"2003","unstructured":"The DAD Study Group (2003) Combination antiretroviral therapy and risk of myocardial infarction. N Engl J Med 349:1993\u20132003","journal-title":"N Engl J Med"},{"key":"591_CR25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00126334-200304150-00004","volume":"32","author":"G. Chironi","year":"2003","unstructured":"Chironi G, Escaut L, Gariepy J et al (2003) Carotid-media thickness in heavily pre-treated HIV-infected patients. J Acquir Immunodef Syndr 32:490\u2013493","journal-title":"J Acquir Immunodef Syndr"},{"key":"591_CR26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200316261","volume":"111","author":"J. Dressman","year":"2003","unstructured":"Dressman J, Kincer J, Matveev SV et al (2003) HIV protease inhibitor promote atherosclerosis lesion formation independent by dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest 111:389\u2013397","journal-title":"J Clin Invest"},{"key":"591_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00002030-200102160-00005","volume":"15","author":"M. Depairon","year":"2001","unstructured":"Depairon M, Chessex S, Sudre P et al (2001) Premature atherosclerosis in HIV-infected individuals. Focus on protease inhibitor therapy. AIDS 15:329\u2013334","journal-title":"AIDS"},{"key":"591_CR28","first-page":"54","volume":"4","author":"R. Ross","year":"1993","unstructured":"Ross R (1993) The pathogenesis of atherosclerosis: a perspectibve for the 1990\u2019s Nature 4:54\u201355","journal-title":"Nature"},{"key":"591_CR29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0046-8177(00)80253-1","volume":"31","author":"R. Chetty","year":"2000","unstructured":"Chetty R, Batitang A, Nair R (2000) Large artery vasculopathy in HIV-positive: another vasculitic enigma Hum Pathol 31:374\u2013378","journal-title":"Hum Pathol"},{"key":"591_CR30","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/01.CIR.0000127577.63323.24","volume":"109","author":"S. Verma","year":"2004","unstructured":"Verma S, Kuliszewski MA, Li SH et al (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109:2058\u20132067","journal-title":"Circulation"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-010-0591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-010-0591-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-010-0591-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T16:32:41Z","timestamp":1559406761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-010-0591-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1007\/s11547-010-0591-3","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,6]]}}}